| Four contiguous amino acid substitutions, identified in patients with Laron syndrome, differently affect the binding affinity and intracellular trafficking of the growth hormone receptor. Wojcik J., Berg M.A., Esposito N., Geffner M.E., Sakati N., Reiter E.O., Dower S., Francke U., Postel-Vinay M.-C., Finidori J.
J. Clin. Endocrinol. Metab. 83:4481-4489(1998) · UniProtKB (1) |
| A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Ross R.J., Esposito N., Shen X.Y., Von Laue S., Chew S.L., Dobson P.R., Postel-Vinay M.-C., Finidori J.
Mol. Endocrinol. 11:265-273(1997) · UniProtKB (1) |
| Lack of hormone binding in COS-7 cells expressing a mutated growth hormone receptor found in Laron dwarfism. Edery M., Rozakis-Adcock M., Goujon L., Finidori J., Levi-Meyrueis C., Paly J., Djiane J., Postel-Vinay M.-C., Kelly P.A.
J. Clin. Invest. 91:838-844(1993) · UniProtKB (1) |
| Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription. Finidori J., Kelly P.A.
J. Endocrinol. 147:11-23(1995) · Mapped (17) |
| A human villin cDNA clone to investigate the differentiation of intestinal and kidney cells in vivo and in culture. Pringault E., Arpin M., Garcia A., Finidori J., Louvard D.
EMBO J. 5:3119-3124(1986) · UniProtKB (1) |
| Sequence of human villin: a large duplicated domain homologous with other actin-severing proteins and a unique small carboxy-terminal domain related to villin specificity. Arpin M., Pringault E., Finidori J., Garcia A., Jeltsch J.-M., Louvard D., van de Kerckhove B.
J. Cell Biol. 107:1759-1766(1988) · UniProtKB (1) |
